ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,447.92
0.79%
Dow Jones
39,387.76
0.85%
Gold vs US Dollar
2,377.145
1.29%
Brent Oil
84.255
0.36%
Bitcoin
63,033.05
-0.02%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Immutep Ltd (IMMP) Share Price

IMMP Immutep Ltd

3.01
0.00 (0.00%)
Pre Market
Last Updated: 10:41:22
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Immutep Ltd NASDAQ:IMMP NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 3.01 2.87 2.97 0.00 0.00  16 09:41:22   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics  -39.9M -0.0336 -13.99 558.03M
 Type  Size  Price  Time  Units 
 9 8 2.88 08:37:20 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore IMMP News
02/05/202413:00GLOBEPositive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma
29/04/202413:00GLOBEImmutep Quarterly Activities Report Q3 FY24
24/04/202413:00GLOBEImmutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
18/04/202413:00GLOBEImmutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
17/04/202413:00GLOBEImmutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
05/03/202413:00GLOBEImmutep Announces First Clinical Data from 90mg Dosing of Efti
30/01/202421:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Period
Draw mode
Data Downloads for IMMP

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Immutep Ltd Articles